Huaren Pharmaceutical Co., Ltd. (300110.SZ)
CNY 2.9
(3.2%)
CNY 2.9
(3.2%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 5.16 Billion CNY | 0.06% |
| 2022 | 5.16 Billion CNY | -8.49% |
| 2021 | 5.64 Billion CNY | 65.17% |
| 2020 | 3.41 Billion CNY | 26.02% |
| 2019 | 2.71 Billion CNY | -13.97% |
| 2018 | 3.15 Billion CNY | 9.12% |
| 2017 | 2.88 Billion CNY | 5.95% |
| 2016 | 2.72 Billion CNY | -0.87% |
| 2015 | 2.74 Billion CNY | 4.85% |
| 2014 | 2.62 Billion CNY | 10.76% |
| 2013 | 2.36 Billion CNY | 32.6% |
| 2012 | 1.78 Billion CNY | 43.08% |
| 2011 | 1.24 Billion CNY | 8.31% |
| 2010 | 1.15 Billion CNY | 81.15% |
| 2009 | 635.78 Million CNY | 25.32% |
| 2008 | 507.33 Million CNY | 40.08% |
| 2007 | 362.17 Million CNY | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q3 | 4.87 Billion CNY | -2.13% |
| 2024 Q1 | 5 Billion CNY | -3.18% |
| 2024 Q2 | 4.97 Billion CNY | -0.45% |
| 2023 Q1 | 5.13 Billion CNY | -0.47% |
| 2023 FY | 5.16 Billion CNY | 0.06% |
| 2023 Q2 | 5.31 Billion CNY | 3.48% |
| 2023 Q3 | 5.17 Billion CNY | -2.72% |
| 2023 Q4 | 5.16 Billion CNY | -0.12% |
| 2022 Q2 | 5.31 Billion CNY | -0.51% |
| 2022 Q4 | 5.16 Billion CNY | 0.94% |
| 2022 FY | 5.16 Billion CNY | -8.49% |
| 2022 Q3 | 5.11 Billion CNY | -3.78% |
| 2022 Q1 | 5.34 Billion CNY | -5.29% |
| 2021 Q3 | 5.78 Billion CNY | 26.04% |
| 2021 Q1 | 4.09 Billion CNY | 19.86% |
| 2021 Q2 | 4.58 Billion CNY | 12.06% |
| 2021 Q4 | 5.64 Billion CNY | -2.43% |
| 2021 FY | 5.64 Billion CNY | 65.17% |
| 2020 FY | 3.41 Billion CNY | 26.02% |
| 2020 Q3 | 2.87 Billion CNY | 6.24% |
| 2020 Q2 | 2.7 Billion CNY | -1.62% |
| 2020 Q4 | 3.41 Billion CNY | 18.81% |
| 2020 Q1 | 2.75 Billion CNY | 1.48% |
| 2019 FY | 2.71 Billion CNY | -13.97% |
| 2019 Q3 | 2.74 Billion CNY | -4.67% |
| 2019 Q4 | 2.71 Billion CNY | -1.16% |
| 2019 Q1 | 3.05 Billion CNY | -3.08% |
| 2019 Q2 | 2.87 Billion CNY | -5.79% |
| 2018 Q4 | 3.15 Billion CNY | -3.16% |
| 2018 FY | 3.15 Billion CNY | 9.12% |
| 2018 Q1 | 3.2 Billion CNY | 10.91% |
| 2018 Q2 | 3.27 Billion CNY | 2.32% |
| 2018 Q3 | 3.25 Billion CNY | -0.7% |
| 2017 Q4 | 2.88 Billion CNY | 1.92% |
| 2017 FY | 2.88 Billion CNY | 5.95% |
| 2017 Q3 | 2.83 Billion CNY | 1.18% |
| 2017 Q2 | 2.79 Billion CNY | 0.02% |
| 2017 Q1 | 2.79 Billion CNY | 2.72% |
| 2016 FY | 2.72 Billion CNY | -0.87% |
| 2016 Q4 | 2.72 Billion CNY | -1.99% |
| 2016 Q3 | 2.78 Billion CNY | 0.71% |
| 2016 Q2 | 2.76 Billion CNY | -3.19% |
| 2016 Q1 | 2.85 Billion CNY | 3.74% |
| 2015 FY | 2.74 Billion CNY | 4.85% |
| 2015 Q1 | 2.67 Billion CNY | 2.07% |
| 2015 Q2 | 2.64 Billion CNY | -0.97% |
| 2015 Q3 | 2.61 Billion CNY | -1.47% |
| 2015 Q4 | 2.74 Billion CNY | 5.28% |
| 2014 Q1 | 2.28 Billion CNY | -3.42% |
| 2014 FY | 2.62 Billion CNY | 10.76% |
| 2014 Q3 | 2.43 Billion CNY | 7.57% |
| 2014 Q2 | 2.26 Billion CNY | -0.85% |
| 2014 Q4 | 2.62 Billion CNY | 7.53% |
| 2013 Q3 | 1.92 Billion CNY | 3.51% |
| 2013 Q4 | 2.36 Billion CNY | 23.01% |
| 2013 FY | 2.36 Billion CNY | 32.6% |
| 2013 Q1 | 1.9 Billion CNY | 6.61% |
| 2013 Q2 | 1.85 Billion CNY | -2.31% |
| 2012 Q1 | 1.48 Billion CNY | 18.71% |
| 2012 Q4 | 1.78 Billion CNY | 3.23% |
| 2012 FY | 1.78 Billion CNY | 43.08% |
| 2012 Q3 | 1.72 Billion CNY | 34.61% |
| 2012 Q2 | 1.28 Billion CNY | -13.26% |
| 2011 Q1 | 1.16 Billion CNY | 0.99% |
| 2011 FY | 1.24 Billion CNY | 8.31% |
| 2011 Q3 | 1.19 Billion CNY | 1.26% |
| 2011 Q2 | 1.18 Billion CNY | 1.55% |
| 2011 Q4 | 1.24 Billion CNY | 4.3% |
| 2010 Q2 | 675.14 Million CNY | 0.0% |
| 2010 Q4 | 1.15 Billion CNY | -0.41% |
| 2010 Q3 | 1.15 Billion CNY | 71.3% |
| 2010 FY | 1.15 Billion CNY | 81.15% |
| 2009 Q4 | 635.78 Million CNY | 0.0% |
| 2009 FY | 635.78 Million CNY | 25.32% |
| 2008 FY | 507.33 Million CNY | 40.08% |
| 2007 FY | 362.17 Million CNY | 0.0% |